This Antibiotic Biotech Is Out of Second Chances at Nasdaq
Lakewood-Amedex did a 1-for-10 reverse split in June. That split is now the reason Nasdaq will not give it the standard compliance period to fix its share price.
Lakewood-Amedex did a 1-for-10 reverse split in June. That split is now the reason Nasdaq will not give it the standard compliance period to fix its share price.
One email each trading morning. Free.